LAMP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.835800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.624000E-01
Normal-vs-Stage2
2.938800E-01
Normal-vs-Stage3
3.390800E-01
Normal-vs-Stage4
7.421800E-01
Stage1-vs-Stage2
8.795600E-01
Stage1-vs-Stage3
8.489800E-02
Stage1-vs-Stage4
5.632200E-01
Stage2-vs-Stage3
2.379600E-01
Stage2-vs-Stage4
5.421400E-01
Stage3-vs-Stage4
6.256500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.227200E-01
Normal-vs-AfricanAmerican
8.379600E-01
Normal-vs-Asian
4.112400E-01
Caucasian-vs-AfricanAmerican
2.361500E-02
Caucasian-vs-Asian
7.726600E-01
AfricanAmerican-vs-Asian
1.728820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.817800E-01
Normal-vs-Female
3.205600E-01
Male-vs-Female
6.200000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.318200E-01
Normal-vs-Age(41-60Yrs)
8.209600E-01
Normal-vs-Age(61-80Yrs)
1.298040E-01
Normal-vs-Age(81-100Yrs)
4.175800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.936700E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.479500E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.046400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.43369999999299E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.475400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.964800E-01
Normal-vs-Daily Drinker
3.610000E-01
Normal-vs-Weekly Drinker
2.236000E-01
Normal-vs-Occasional Drinker
6.416400E-01
Normal-vs-Social Drinker
4.810800E-01
Non Drinker-vs-Daily Drinker
1.000590E-01
Non Drinker-vs-Weekly Drinker
8.921000E-01
Non Drinker-vs-Occasional Drinker
1.880810E-01
Non Drinker-vs-Social Drinker
5.953600E-01
Daily Drinker-vs-Weekly Drinker
1.386430E-01
Daily Drinker-vs-Occasional Drinker
2.344100E-03
Daily Drinker-vs-Social Drinker
7.581700E-02
Weekly Drinker-vs-Occasional Drinker
1.582220E-01
Weekly Drinker-vs-Social Drinker
5.285600E-01
Occasional Drinker-vs-Social Drinker
5.259400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.960200E-01
Normal-vs-Grade 2
7.701000E-01
Normal-vs-Grade 3
3.679000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.943400E-01
Grade 1-vs-Grade 3
9.092600E-01
Grade 1-vs-Grade 4
4.960200E-01
Grade 2-vs-Grade 3
4.422800E-01
Grade 2-vs-Grade 4
7.701000E-01
Grade 3-vs-Grade 4
3.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.396230E-01
Normal-vs-NonDiabetic
2.293800E-01
Diabetic-vs-NonDiabetic
3.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.329160E-01
Normal-vs-NoPancreatitis
2.344800E-01
Pancreatitis-vs-NoPancreatitis
2.639200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.391800E-01
Normal-vs-N1
3.275800E-01
N0-vs-N1
5.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.683600E-01
Normal-vs-TP53-NonMutant
2.499000E-01
TP53-Mutant-vs-TP53-NonMutant
5.020000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
